The FDA advises against their use in people with a personal or family history of medullary thyroid carcinoma (MTC), in those with Multiple Endocrine Neoplasia type 2 (MEN2), or in patients with severe gastroparesis or past serious allergic reactions
After a health assessment reviewed by an affiliated provider, eligible patients can access GLP-1 medication along with ongoing app-based support
Major health plans and PBMs have built institutional knowledge of how to structure formulary decisions, step therapy requirements, and prior authorization criteria to accelerate biosimilar adoption and have financial incentives to deploy that knowledge more aggressively than in the adalimumab cycle
This guide highlights key risks and provides actionable, evidence-backed solutions to help you build a smarter, more forward-thinking health benefits strategy
Strong hair growth requires healthy hair follicles, which glutathione helps to maintain